Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis
Trial details
- Registry ID
- NCT05962788
- Drugs studied
- voclosporin
TrialRedline tracks 2 clinical trials sponsored by Aurinia Pharmaceuticals Inc.: 2 Phase 3.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus NephritisNCT05962788 | voclosporin | Terminated | 2025-07-04Actual |
| Voclosporin in Adolescent and Pediatric Subjects With Lupus NephritisNCT05288855 | Voclosporin | Terminated | 2025-07-03Actual |
Names as written in the registry records.
NCT05962788 · Aurinia Pharmaceuticals Inc.
Before: Estimated. After: Actual.
Before: 40 participants (planned). After: 4 participants (actual).
Before: Estimated. After: Actual.
Before: Dec 2028. After: 4 Jul 2025.
Before: Enrolling by invitation. After: Terminated.
NCT05288855 · Aurinia Pharmaceuticals Inc.
Before: Estimated. After: Actual.
Before: 40 participants (planned). After: 9 participants (actual).
Before: Estimated. After: Actual.
Before: Dec 2027. After: 3 Jul 2025.
Before: Recruiting. After: Terminated.